A Study to Evaluate Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Children (MK-0869-219)

NCT01732458 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

229

Enrollment

INDUSTRY

Sponsor class

Conditions

Post-operative Nausea
Post-operative Vomiting

Interventions

DRUG: Aprepitant
DRUG: Placebo to Aprepitant
DRUG: Ondansetron
DRUG: Placebo to match ondansetron

Sponsor

Merck Sharp & Dohme LLC